• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病中的血液酶与氧化应激:一项横断面研究

Blood enzymes and oxidative stress in chronic kidney disease: a cross sectional study.

作者信息

Johnson-Davis Kamisha L, Fernelius Colby, Eliason Nathan B, Wilson Andrew, Beddhu Srinivasan, Roberts William L

机构信息

Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT, USA.

出版信息

Ann Clin Lab Sci. 2011 Fall;41(4):331-9.

PMID:22166502
Abstract

BACKGROUND

Cardiovascular disease causes morbidity and mortality in chronic kidney disease. Increased formation of oxygen-derived radicals can accelerate the development of atherosclerosis. Several studies have shown an imbalance in antioxidant activity, resulting in high oxidative stress and lipid peroxidation, in subjects undergoing hemodialysis.

METHODS

Eighty-nine subjects with chronic kidney disease and varying degrees of renal impairment, some of who were undergoing peritoneal or hemodialysis, were studied and compared with a group of healthy controls. F2-isoprostanes, selenium, and oxidized low density lipoprotein (LDL) concentrations were used as markers for in vivo oxidative stress; paraoxonase and glutathione peroxidase were used as markers of antioxidant activity.

RESULTS

We quantified serum F2-isoprostanes, paraoxonase, selenium, oxidized LDL, and RBC glutathione and compared the treatment regimens using post-hoc pair-wise comparisons and Tukey's honest statistical difference. A significant increase in oxidative stress between the hemodialysis and control group was noted. The renal insufficiency and peritoneal dialysis groups showed increased oxidative stress and decreased antioxidant capacity, reaching statistical significance for some serum analytes. Selenium concentrations and oxidized LDL did not vary significantly between the hemodialysis and control groups.

CONCLUSION

These data suggest that increased oxidative stress and decreased antioxidant activity are associated with declining renal function.

摘要

背景

心血管疾病导致慢性肾脏病患者发病和死亡。氧自由基生成增加会加速动脉粥样硬化的发展。多项研究表明,接受血液透析的患者抗氧化活性失衡,导致氧化应激和脂质过氧化水平升高。

方法

对89例患有不同程度肾功能损害的慢性肾脏病患者进行研究,其中部分患者接受腹膜透析或血液透析,并与一组健康对照者进行比较。F2-异前列腺素、硒和氧化型低密度脂蛋白(LDL)浓度用作体内氧化应激的标志物;对氧磷酶和谷胱甘肽过氧化物酶用作抗氧化活性的标志物。

结果

我们对血清F2-异前列腺素、对氧磷酶、硒、氧化型LDL以及红细胞谷胱甘肽进行了定量分析,并使用事后两两比较和Tukey真实统计差异法对治疗方案进行了比较。血液透析组与对照组之间的氧化应激显著增加。肾功能不全组和腹膜透析组的氧化应激增加,抗氧化能力下降,部分血清分析物达到统计学显著水平。血液透析组与对照组之间的硒浓度和氧化型LDL没有显著差异。

结论

这些数据表明,氧化应激增加和抗氧化活性降低与肾功能下降有关。

相似文献

1
Blood enzymes and oxidative stress in chronic kidney disease: a cross sectional study.慢性肾脏病中的血液酶与氧化应激:一项横断面研究
Ann Clin Lab Sci. 2011 Fall;41(4):331-9.
2
Glutathione, glutathione-related enzymes, and total antioxidant capacity in patients on maintenance dialysis.维持性透析患者的谷胱甘肽、谷胱甘肽相关酶及总抗氧化能力
Iran J Kidney Dis. 2009 Jan;3(1):22-7.
3
Assessment of the antioxidant status and markers of oxidative stress in patients with kidney failure: effects of a hemodialysis session.评估肾衰竭患者的抗氧化状态和氧化应激标志物:血液透析治疗的影响。
An Acad Bras Cienc. 2024 Sep 16;96(suppl 1):e20240297. doi: 10.1590/0001-3765202420240297. eCollection 2024.
4
[The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].[血液透析对慢性肾衰竭患者血液中抗氧化系统某些参数的影响]
Ann Acad Med Stetin. 2004;50(1):41-52.
5
Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure.谷胱甘肽抗氧化系统作为慢性肾衰竭氧化应激的标志物
Free Radic Biol Med. 1996;21(6):845-53. doi: 10.1016/0891-5849(96)00233-x.
6
Study of oxidative stress in patients with advanced renal disease and undergoing either hemodialysis or peritoneal dialysis.晚期肾病患者接受血液透析或腹膜透析时的氧化应激研究。
Clin Nephrol. 2013 Sep;80(3):177-86. doi: 10.5414/CN107639.
7
Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients.血液透析患者血浆和低密度脂蛋白氧化捕捉潜力的批判性评估。
Kidney Int. 1999 Aug;56(2):747-53. doi: 10.1046/j.1523-1755.1999.00565.x.
8
Effect of hemodialysis on oxidants and antioxidant factors in chronic renal failure.血液透析对慢性肾衰竭患者氧化剂和抗氧化因子的影响
Saudi J Kidney Dis Transpl. 2017 May-Jun;28(3):507-516. doi: 10.4103/1319-2442.206446.
9
Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients.血液透析和持续性非卧床腹膜透析患者的红细胞谷胱甘肽过氧化物酶活性、血浆丙二醛及红细胞谷胱甘肽水平
Clin Biochem. 2002 Jun;35(4):269-73. doi: 10.1016/s0009-9120(02)00307-7.
10
A Meta-Analysis of Oxidative Stress Markers in Depression.抑郁症氧化应激标志物的荟萃分析
PLoS One. 2015 Oct 7;10(10):e0138904. doi: 10.1371/journal.pone.0138904. eCollection 2015.

引用本文的文献

1
The importance of paraoxonase 1 activity in chronic kidney disease.对慢性肾脏病患者血清对氧磷酶 1 活性的重视。
Ren Fail. 2024 Dec;46(2):2376930. doi: 10.1080/0886022X.2024.2376930. Epub 2024 Jul 10.
2
Paraoxonase 1 Activity and Renal Replacement Therapy for Chronic Renal Failure: A Meta-Analysis.对氧磷酶1活性与慢性肾衰竭的肾脏替代治疗:一项荟萃分析
J Clin Med. 2023 Aug 4;12(15):5123. doi: 10.3390/jcm12155123.
3
Novel oxidized LDL-based clinical markers in peritoneal dialysis patients for atherosclerosis risk assessment.新型基于氧化 LDL 的腹膜透析患者临床标志物用于动脉粥样硬化风险评估。
Redox Biol. 2023 Aug;64:102762. doi: 10.1016/j.redox.2023.102762. Epub 2023 Jun 2.
4
Paraoxonase 1 and Chronic Kidney Disease: A Meta-Analysis.对氧磷酶1与慢性肾脏病:一项荟萃分析
J Clin Med. 2023 Feb 2;12(3):1199. doi: 10.3390/jcm12031199.
5
Methods on LDL particle isolation, characterization, and component fractionation for the development of novel specific oxidized LDL status markers for atherosclerotic disease risk assessment.用于开发新型特异性氧化低密度脂蛋白状态标志物以评估动脉粥样硬化疾病风险的低密度脂蛋白颗粒分离、表征和成分分级方法。
Front Med (Lausanne). 2023 Jan 5;9:1078492. doi: 10.3389/fmed.2022.1078492. eCollection 2022.
6
Head-to-Head Comparison of Oxidative Stress Biomarkers for All-Cause Mortality in Hemodialysis Patients.血液透析患者全因死亡率氧化应激生物标志物的头对头比较
Antioxidants (Basel). 2022 Oct 2;11(10):1975. doi: 10.3390/antiox11101975.
7
Indoxyl sulfate, homocysteine, and antioxidant capacities in patients at different stages of chronic kidney disease.慢性肾脏病不同阶段患者的硫酸吲哚酚、同型半胱氨酸及抗氧化能力
Nutr Res Pract. 2022 Aug;16(4):464-475. doi: 10.4162/nrp.2022.16.4.464. Epub 2021 Dec 2.
8
Vascular Calcification in Chronic Kidney Disease: Distinct Features of Pathogenesis and Clinical Implication.慢性肾脏病中的血管钙化:发病机制的独特特征及临床意义
Korean Circ J. 2021 Dec;51(12):961-982. doi: 10.4070/kcj.2021.0995.
9
Oxidized LDL Is Associated with eGFR Decline in Proteinuric Diabetic Kidney Disease: A Cohort Study.氧化型 LDL 与蛋白尿性糖尿病肾病患者 eGFR 下降相关:一项队列研究。
Oxid Med Cell Longev. 2021 Oct 19;2021:2968869. doi: 10.1155/2021/2968869. eCollection 2021.
10
Oxidative Stress in Patients with Advanced CKD and Renal Replacement Therapy: The Key Role of Peripheral Blood Leukocytes.晚期慢性肾脏病患者及肾脏替代治疗中的氧化应激:外周血白细胞的关键作用
Antioxidants (Basel). 2021 Jul 20;10(7):1155. doi: 10.3390/antiox10071155.